{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:48:32Z","timestamp":1793944112669,"version":"4.8.0"},"reference-count":95,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T00:00:00Z","timestamp":1622332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Autism spectrum disorder (ASD) is a neurodevelopmental disorder affecting approximately 2% of children in the United States. Growing evidence suggests that immune dysregulation is associated with ASD. One immunomodulatory treatment that has been studied in ASD is intravenous immunoglobulins (IVIG). This systematic review and meta-analysis examined the studies which assessed immunoglobulin G (IgG) concentrations and the therapeutic use of IVIG for individuals with ASD. Twelve studies that examined IgG levels suggested abnormalities in total IgG and IgG 4 subclass concentrations, with concentrations in these IgGs related to aberrant behavior and social impairments, respectively. Meta-analysis supported possible subsets of children with ASD with low total IgG and elevated IgG 4 subclass but also found significant variability among studies. A total of 27 publications reported treating individuals with ASD using IVIG, including four prospective, controlled studies (one was a double-blind, placebo-controlled study); six prospective, uncontrolled studies; 2 retrospective, controlled studies; and 15 retrospective, uncontrolled studies. In some studies, clinical improvements were observed in communication, irritability, hyperactivity, cognition, attention, social interaction, eye contact, echolalia, speech, response to commands, drowsiness, decreased activity and in some cases, the complete resolution of ASD symptoms. Several studies reported some loss of these improvements when IVIG was stopped. Meta-analysis combining the aberrant behavior checklist outcome from two studies demonstrated that IVIG treatment was significantly associated with improvements in total aberrant behavior and irritability (with large effect sizes), and hyperactivity and social withdrawal (with medium effect sizes). Several studies reported improvements in pro-inflammatory cytokines (including TNF-alpha). Six studies reported improvements in seizures with IVIG (including patients with refractory seizures), with one study reporting a worsening of seizures when IVIG was stopped. Other studies demonstrated improvements in recurrent infections, appetite, weight gain, neuropathy, dysautonomia, and gastrointestinal symptoms. Adverse events were generally limited but included headaches, vomiting, worsening behaviors, anxiety, fever, nausea, fatigue, and rash. Many studies were limited by the lack of standardized objective outcome measures. IVIG is a promising and potentially effective treatment for symptoms in individuals with ASD; further research is needed to provide solid evidence of efficacy and determine the subset of children with ASD who may best respond to this treatment as well as to investigate biomarkers which might help identify responsive candidates.<\/jats:p>","DOI":"10.3390\/jpm11060488","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T01:51:37Z","timestamp":1622425897000},"page":"488","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["A Systematic Review and Meta-Analysis of Immunoglobulin G Abnormalities and the Therapeutic Use of Intravenous Immunoglobulins (IVIG) in Autism Spectrum Disorder"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4405-8664","authenticated-orcid":false,"given":"Daniel A","family":"Rossignol","sequence":"first","affiliation":[{"name":"Rossignol Medical Center, 24541 Pacific Park Drive, Suite 210, Aliso Viejo, CA 92656, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4442-2937","authenticated-orcid":false,"given":"Richard E","family":"Frye","sequence":"additional","affiliation":[{"name":"Barrow Neurological Institute at Phoenix Children\u2019s Hospital, 1919 E Thomas Rd, Phoenix, AZ 85016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6904a1","article-title":"Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years\u2014Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2016","volume":"69","author":"Maenner","year":"2020","journal-title":"Mmwr. Surveill Summ."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"101502","DOI":"10.1016\/j.rasd.2019.101502","article-title":"The lifetime social cost of autism: 1990\u20132029","volume":"72","author":"Cakir","year":"2020","journal-title":"Res. Autism Spectr. Disord."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/mp.2010.136","article-title":"Mitochondrial dysfunction in autism spectrum disorders: A systematic review and meta-analysis","volume":"17","author":"Rossignol","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"ref_4","unstructured":"Matson, J.L., and Sturmey, P. (2020). Psychotropic Medications for Sleep Disorders in Autism Spectrum Disorders. Handbook on Autism and Pervasive Developmental Disorde\u2014Assessment, Diagnosis and Treatmeny, Springer Nature."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/aur.2128","article-title":"Clustering of co-occurring conditions in autism spectrum disorder during early childhood: A retrospective analysis of medical claims data","volume":"12","author":"Vargason","year":"2019","journal-title":"Autism Res. Off. J. Int. Soc. Autism Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/aur.1854","article-title":"Gastrointestinal symptoms in autism spectrum disorder: A review of the literature on ascertainment and prevalence","volume":"11","author":"Holingue","year":"2018","journal-title":"Autism Res. Off. J. Int. Soc. Autism Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpsychires.2020.07.013","article-title":"Microglia mediated neuroinflammation in autism spectrum disorder","volume":"130","author":"Liao","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s12098-019-02977-6","article-title":"Prevalence of Epilepsy and Inter-Ictal Epileptiform Discharges in Children with Autism and Attention-Deficit Hyperactivity Disorder","volume":"86","author":"Anukirthiga","year":"2019","journal-title":"Indian J. Pediatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1007\/s10803-015-2507-5","article-title":"Treatment for Sleep Problems in Children with Autism and Caregiver Spillover Effects","volume":"45","author":"Tilford","year":"2015","journal-title":"J. Autism Dev. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/mp.2011.165","article-title":"A review of research trends in physiological abnormalities in autism spectrum disorders: Immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures","volume":"17","author":"Rossignol","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/aur.1979","article-title":"Family history of immune conditions and autism spectrum and developmental disorders: Findings from the study to explore early development","volume":"12","author":"Croen","year":"2019","journal-title":"Autism Res. Off. J. Int. Soc. Autism Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.neubiorev.2015.05.004","article-title":"Family history of autoimmune diseases is associated with an increased risk of autism in children: A systematic review and meta-analysis","volume":"55","author":"Wu","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ramirez-Celis, A., Becker, M., Nu\u00f1o, M., Schauer, J., Aghaeepour, N., and Van de Water, J. (2021). Risk assessment analysis for maternal autoantibody-related autism (MAR-ASD): A subtype of autism. Mol. Psychiatry.","DOI":"10.1038\/s41380-020-00998-8"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.biopsych.2018.08.008","article-title":"Maternal Inflammation and Neurodevelopmental Programming: A Review of Preclinical Outcomes and Implications for Translational Psychiatry","volume":"85","author":"Gumusoglu","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fpsyt.2019.00612","article-title":"Inheritance of HLA-Cw7 Associated With Autism Spectrum Disorder (ASD)","volume":"10","author":"Harville","year":"2019","journal-title":"Front. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fpsyt.2019.00071","article-title":"Variations in Mitochondrial Respiration Differ in IL-1\u00df\/IL-10 Ratio Based Subgroups in Autism Spectrum Disorders","volume":"10","author":"Jyonouchi","year":"2019","journal-title":"Front. Psychiatry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12974-017-1003-6","article-title":"MicroRNA expression changes in association with changes in interleukin-1\u00df\/interleukin10 ratios produced by monocytes in autism spectrum disorders: Their association with neuropsychiatric symptoms and comorbid conditions (observational study)","volume":"14","author":"Jyonouchi","year":"2017","journal-title":"J Neuroinflamm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.20315","article-title":"Neuroglial activation and neuroinflammation in the brain of patients with autism","volume":"57","author":"Vargas","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41398-018-0214-7","article-title":"Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism","volume":"8","author":"Connery","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/mp.2011.175","article-title":"Cerebral folate receptor autoantibodies in autism spectrum disorder","volume":"18","author":"Frye","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1007\/s10875-010-9402-9","article-title":"Adaptive and Innate Immune Responses in Autism: Rationale for Therapeutic Use of Intravenous Immunoglobulin","volume":"30","author":"Gupta","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"AB231","DOI":"10.1016\/j.jaci.2010.12.920","article-title":"Characterization Of Children With Autism Spectrum Disorders (asd) Requiring Intravenous Immunoglobulin (ivig) For Specific Polysaccharide Antibody Deficiency (spad)\/hypogammaglobulinemia-Distinct Patterns Of Cytokine Production And Gene Expression Profiles","volume":"127","author":"Jyonouchi","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/aur.42","article-title":"Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms","volume":"1","author":"Heuer","year":"2008","journal-title":"Autism Res. Off. J. Int. Soc. Autism Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"106325","DOI":"10.1016\/j.eplepsyres.2020.106325","article-title":"Immunotherapy for GRIN2A and GRIN2D-related epileptic encephalopathy","volume":"163","author":"Menascu","year":"2020","journal-title":"Epilepsy Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pediatrneurol.2012.03.015","article-title":"Immunoglobulin treatment for severe childhood epilepsy","volume":"46","author":"Shorer","year":"2012","journal-title":"Pediatr. Neurol."},{"key":"ref_26","first-page":"204","article-title":"Intravenous high-dose gammaglobulins for intractable childhood epilepsy","volume":"88","author":"Shalev","year":"1993","journal-title":"Acta Neurol. Scand."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nri3401","article-title":"Intravenous immunoglobulin therapy: How does IgG modulate the immune system?","volume":"13","author":"Schwab","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.it.2008.08.004","article-title":"Modulation of the cellular immune system by intravenous immunoglobulin","volume":"29","author":"Bayry","year":"2008","journal-title":"Trends Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10875-007-9088-9","article-title":"Intravenous immunoglobulin: An update on the clinical use and mechanisms of action","volume":"27","author":"Negi","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"ref_32","first-page":"n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"ref_33","unstructured":"Higgins, J.P.T., and Green, S. (2011). Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions, The Cochrane Collaboration. [Version 5.1.0 ed.]."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s10803-006-0141-y","article-title":"Oral human immunoglobulin for children with autism and gastrointestinal dysfunction: A prospective, open-label study","volume":"36","author":"Schneider","year":"2006","journal-title":"J. Autism Dev. Disord."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s10803-008-0687-y","article-title":"A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder","volume":"39","author":"Handen","year":"2009","journal-title":"J. Autism Dev. Disord."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1023\/A:1005568027292","article-title":"Immunological treatments for autism","volume":"30","author":"Gupta","year":"2000","journal-title":"J. Autism Dev. Disord."},{"key":"ref_37","unstructured":"Altman, D.G., Machin, D., Bryant, T.N., and Gardner, M.J. (2000). Statistics with Confidence, BMJ Books. [2nd ed.]."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Higgins, J.P.T., and Green, S. (2008). Cochrane Handbook for Systematic Reviews of Interventions, Wiley Online Library.","DOI":"10.1002\/9780470712184"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cct.2015.05.009","article-title":"Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model","volume":"45","author":"Doi","year":"2015","journal-title":"Contemp. Clin. Trials"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/jech-2013-203104","article-title":"Meta-analysis of prevalence","volume":"67","author":"Barendregt","year":"2013","journal-title":"J. Epidemiol. Community Health"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/XEB.0000000000000141","article-title":"A new improved graphical and quantitative method for detecting bias in meta-analysis","volume":"16","author":"Barendregt","year":"2018","journal-title":"Int. J. Evid. Based Healthc."},{"key":"ref_44","first-page":"236","article-title":"The way in which intervention studies have \"personality\" and why it is important to meta-analysis","volume":"24","author":"Lipsey","year":"2001","journal-title":"Eval. Health Prof."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/sim.2639","article-title":"Trying to be precise about vagueness","volume":"26","author":"Senn","year":"2007","journal-title":"Stat Med."},{"key":"ref_46","unstructured":"Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences, Lawrence Erlbaum Associates. [2nd ed.]."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1017\/S0033291702006037","article-title":"Increased serum albumin, gamma globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism","volume":"32","author":"Croonenberghs","year":"2002","journal-title":"Psychol. Med."},{"key":"ref_48","first-page":"746","article-title":"Plasma concentration of immunoglobulin classes and subclasses in children with autism in the Republic of Macedonia: Retrospective study","volume":"45","author":"Trajkovski","year":"2004","journal-title":"Croat. Med. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbi.2008.12.005","article-title":"Increased IgG4 levels in children with autism disorder","volume":"23","author":"Enstrom","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.17305\/bjbms.2009.2780","article-title":"Family analysis of immunoglobulin classes and subclasses in children with autistic disorder","volume":"9","author":"Spiroski","year":"2009","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"324","DOI":"10.5114\/aoms.2012.28561","article-title":"Low serum IgA and increased expression of CD23 on B lymphocytes in peripheral blood in children with regressive autism aged 3-6 years old","volume":"8","author":"Wasilewska","year":"2012","journal-title":"Arch. Med. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF02172828","article-title":"Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics","volume":"26","author":"Gupta","year":"1996","journal-title":"J. Autism Dev. Disord."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1081-1206(10)61019-8","article-title":"Immune function in autistic children","volume":"95","author":"Stern","year":"2005","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/aur.160","article-title":"Neonatally measured immunoglobulins and risk of autism","volume":"3","author":"Grether","year":"2010","journal-title":"Autism Res. Off. J. Int. Soc. Autism Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fnins.2016.00218","article-title":"Prenatal and Newborn Immunoglobulin Levels from Mother-Child Pairs and Risk of Autism Spectrum Disorders","volume":"10","author":"Grether","year":"2016","journal-title":"Front. Neurosci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0002-7138(09)61589-2","article-title":"Childhood autism. Cerebrospinal fluid examination and immunoglobulin levels","volume":"16","author":"Young","year":"1977","journal-title":"J. Am. Acad. Child Psychiatry"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Runge, K., Tebartz van Elst, L., Maier, S., Nickel, K., Denzel, D., Matysik, M., Kuzior, H., Robinson, T., Blank, T., and Dersch, R. (2020). Cerebrospinal Fluid Findings of 36 Adult Patients with Autism Spectrum Disorder. Brain Sci., 10.","DOI":"10.3390\/brainsci10060355"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/sj.npp.1300130","article-title":"Immunoglobulins as an alternative strategy of psychopharmacological treatment of children with autistic disorder","volume":"28","author":"Niederhofer","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneuroim.2011.07.001","article-title":"Children with autism spectrum disorders (ASD) who exhibit chronic gastrointestinal (GI) symptoms and marked fluctuation of behavioral symptoms exhibit distinct innate immune abnormalities and transcriptional profiles of peripheral blood (PB) monocytes","volume":"238","author":"Jyonouchi","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"ref_60","first-page":"35","article-title":"High-Dose Intravenous Immunoglobulin Therapy Efficiency in Children with Autism Spectrum Disorders Associated with Genetic Deficiency of Folate Cycle Enzymes","volume":"2","author":"Maltsev","year":"2016","journal-title":"Int. Neurol. J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/088307389801300207","article-title":"Intravenous immunoglobulin treatment of children with autism","volume":"13","author":"Plioplys","year":"1998","journal-title":"J. Child Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/A:1023096728131","article-title":"Brief report: A pilot open clinical trial of intravenous immunoglobulin in childhood autism","volume":"29","author":"Simon","year":"1999","journal-title":"J. Autism. Dev. Disord."},{"key":"ref_63","first-page":"22","article-title":"Another view of autism","volume":"Winter","author":"Oleske","year":"2004","journal-title":"UMDNJ Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.clim.2006.04.278","article-title":"Sa. 46. Autism as a Neuro-Immune Disease-the Benefit Effect of IVIG","volume":"119","author":"Melamed","year":"2006","journal-title":"Clin. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/aur.1906","article-title":"A pilot study of high-dose intravenous immunoglobulin 5% for autism: Impact on autism spectrum and markers of neuroinflammation","volume":"11","author":"Melamed","year":"2018","journal-title":"Autism Res. Off. J. Int. Soc. Autism Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/13590840600681827","article-title":"Improvement in children with autism treated with intravenous gamma globulin","volume":"15","author":"Boris","year":"2005","journal-title":"J. Nutr. Environ. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/pai.1998.12.213","article-title":"High-dose intravenous immunoglobulin therapy in three children with seizure disorders and autistic features","volume":"12","author":"Knutsen","year":"1998","journal-title":"Pediatr. Asthma Allergy Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-2094-9-4","article-title":"Immunological characterization and transcription profiling of peripheral blood (PB) monocytes in children with autism spectrum disorders (ASD) and specific polysaccharide antibody deficiency (SPAD): Case study","volume":"9","author":"Jyonouchi","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/21556660.2018.1521073","article-title":"Evaluating possible use of IVIG in autism spectrum disorder (ASD)","volume":"7","author":"Fadeyi","year":"2018","journal-title":"J. Drug Assess."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s13760-016-0614-5","article-title":"Atypical enterovirus encephalitis causing behavioral changes and autism-like clinical manifestations: Case report","volume":"116","author":"Akcakaya","year":"2016","journal-title":"Acta Neurol. Belg."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/S1090-3798(15)30416-5","article-title":"P103\u20142340: Atypical enterovirus encephalitis causing behavioral changes and autism-like clinical manifestations: Case report","volume":"19","author":"Akcakaya","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_72","first-page":"S2","article-title":"Intravenous Immunoglobulin (IVIG) Therapy in an Autistic Child with Common Variable Immune Deficiency (CVID)-Case Report","volume":"99","author":"Suez","year":"1997","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaci.2005.02.021","article-title":"Common variable immunodeficiency presenting with a large abdominal mass","volume":"115","author":"Wang","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_74","first-page":"287","article-title":"Autism in a child with common variable immunodeficiency","volume":"12","author":"Aghamohammadi","year":"2013","journal-title":"Iran J. Allergy Asthma Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1090-3798(08)70593-2","article-title":"CBP012 Chronic demyelinating neuropathy with multiple vitamin deficiencies in a child with autism","volume":"11","author":"Sommerville","year":"2007","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_76","first-page":"951","article-title":"Demyelinating neuropathy in a 6-year-old girl with autism spectrum disorder","volume":"59","author":"Kamata","year":"2017","journal-title":"Pediatr. Int. Off. J. Jpn. Pediatr. Soc."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1177\/0883073813501875","article-title":"Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis: An unusual cause of autistic regression in a toddler","volume":"29","author":"Scott","year":"2014","journal-title":"J. Child Neurol."},{"key":"ref_78","first-page":"504","article-title":"[Anti-NMDA receptor encephalitis: Two paediatric cases]","volume":"57","year":"2013","journal-title":"Rev. Neurol."},{"key":"ref_79","first-page":"161","article-title":"Subacute encephalitis in a child seropositive for alpha-3 subunit of neuronal nicotinic acetylcholine receptors antibody","volume":"12","author":"Menon","year":"2014","journal-title":"J. Pediatr. Neurol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"256","DOI":"10.17554\/j.issn.2313-5611.2016.02.44","article-title":"Infection-Induced Autoimmune Encephalopathy: Treatment with Intravenous Immune Globulin Therapy. A Report of Six Patients","volume":"2","author":"Bouboulis","year":"2016","journal-title":"Int. J. Neurol. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"99","DOI":"10.14802\/jmd.16058","article-title":"Progressive Encephalomyelitis with Rigidity and Myoclonus in an Intellectually Disabled Patient Mimicking Neuroleptic Malignant Syndrome","volume":"10","author":"Xu","year":"2017","journal-title":"J. Mov. Disord."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/aur.2015","article-title":"Otitis media, antibiotics, and risk of autism spectrum disorder","volume":"11","author":"Wimberley","year":"2018","journal-title":"Autism Res. Off. J. Int. Soc. Autism Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1007\/s10803-015-2689-x","article-title":"Otitis Media and Related Complications Among Children with Autism Spectrum Disorders","volume":"46","author":"Adams","year":"2016","journal-title":"J. Autism Dev. Disord."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02098863","article-title":"The UCLA-University of Utah epidemiologic survey of autism: Recurrent infections","volume":"2","author":"Ritvo","year":"1993","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-2094-5-52","article-title":"Impact of innate immunity in a subset of children with autism spectrum disorders: A case control study","volume":"5","author":"Jyonouchi","year":"2008","journal-title":"J. Neuroinflamm."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12974-014-0187-2","article-title":"Cytokine profiles by peripheral blood monocytes are associated with changes in behavioral symptoms following immune insults in a subset of ASD subjects: An inflammatory subtype?","volume":"11","author":"Jyonouchi","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"iii123","DOI":"10.1093\/rheumatology\/kez667","article-title":"IgG4-related disease: A clinical perspective","volume":"59","author":"Maritati","year":"2020","journal-title":"Rheumatol. Oxf. Engl."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Lim, A.H., Wong, S., and Nguyen, N.Q. (2021). Eosinophilic Esophagitis and IgG4: Is There a Relationship?. Dig. Dis. Sci.","DOI":"10.1007\/s10620-020-06788-0"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1097\/MPG.0000000000001282","article-title":"Feeding Disorders in Children With Autism Spectrum Disorders Are Associated With Eosinophilic Esophagitis","volume":"63","author":"Heifert","year":"2016","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13073-020-00789-4","article-title":"Microbial signature in IgE-mediated food allergies","volume":"12","author":"Goldberg","year":"2020","journal-title":"Genome Med."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Lee, K.H., Guo, J., Song, Y., Ariff, A., O\u2019Sullivan, M., Hales, B., Mullins, B.J., and Zhang, G. (2021). Dysfunctional Gut Microbiome Networks in Childhood IgE-Mediated Food Allergy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22042079"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Andreo-Mart\u00ednez, P., Rubio-Aparicio, M., S\u00e1nchez-Meca, J., Veas, A., and Mart\u00ednez-Gonz\u00e1lez, A.E. (2021). A Meta-analysis of Gut Microbiota in Children with Autism. J. Autism Dev. Disord.","DOI":"10.1007\/s10803-021-05002-y"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Roussin, L., Prince, N., Perez-Pardo, P., Kraneveld, A.D., Rabot, S., and Naudon, L. (2020). Role of the Gut Microbiota in the Pathophysiology of Autism Spectrum Disorder: Clinical and Preclinical Evidence. Microorganisms, 8.","DOI":"10.3390\/microorganisms8091369"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11882-009-0029-y","article-title":"Food allergy and autism spectrum disorders: Is there a link?","volume":"9","author":"Jyonouchi","year":"2009","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"100836","DOI":"10.1016\/j.spen.2020.100836","article-title":"Immune Modulatory Treatments for Autism Spectrum Disorder","volume":"35","author":"Thom","year":"2020","journal-title":"Semin. Pediatr. Neurol."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/6\/488\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:09:05Z","timestamp":1760162945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/6\/488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,30]]},"references-count":95,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["jpm11060488"],"URL":"https:\/\/doi.org\/10.3390\/jpm11060488","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,30]]}}}